ÚÀÓ´£¬×î½üÓÐÈËÅÜÀ´¸úÎÒ½²£¬ËµÊ²Ã´¡°×ñÒåÄϰ׶«´ó½Ö¿ì²Í±ãÒ˵úܣ¬Ëæ±ã³Ô£¡¡±ÎÒÅÞ£¡ÄãÏþµÃ¸öÂÑ£¡ÎÒ½ñÌì¾ÍÒª¸úÄãêþ³¶Çå³þ£¬ÄãĪÒÔΪÎÒÕâÀϹðÁø²»¶®×ñÒåµÄÊÂà磡Äϰ׶«´ó½ÖµÄ¿ì²Í£¬±íÃæÉÏ¿´ÊDZãÒË£¬Êµ¼ÊÀïÃæÍäÍäÈÆÏñ¹ðÁÖÁ½½ËĺþµÄË®µÀ£¬¸ãµÃÈËÔÎͷתÏò£¡À´À´À´£¬ÄãÌýÎÒ½²Çå³þÂ
±ãÒËÊDZãÒË£¬Ã¨ÄåÊǶàµÃºÜàç
Äã½²ÂÄϰ׶«´ó½ÖµÄС¿ì²Íµê£¬È·ÊµÊǹҸöÅÆ×Óд¡°8¿éǮһÌס±£¬¿´ÆðÀ´µÖµÃ»Å¡£ÄÇÊDz»ÊÇÕæµÖ£¿ÄãÂýµã£¡ÄãÈ¥µãÒ»·ÝÊÔÊÔ£¬ÀϰåÄï¾ÍÎÊÄ㣺¡°¼Ó²»¼ÓÈ⣿¼Ó²»¼Óµ°£¿¡±ÄãÒªÊÇËæÊÖµã¸ö¡°¼ÓÁËÂ£¬ºÙºÙ£¬×îºóÒ»½áÕË£¬14¿é¶¼Åܲ»µô£¡Äã½²ÊDz»ÊÇ¿©£¿
¶øÇÒÄÇЩ10¿éÇ®ÒÔϵĿì²ÍÂ²ËÊǶ࣬µ«Î¶µÀÒ»°ã¾ÍµÃºÜ¡£ÓͶàµÃÏñ°×¹ûÔ°Ïï×ÓÀïµÄÀÏÓÍÌõ̯×Ó£¬³ÔÒ»¿ÚÄåµÃ»Å£»²ËÂÇàµÄÇà¡¢»ÆµÄ»Æ£¬ÖóµÃÀϵÃÏñÎÒ¼Ò°¢°ÖµÄÑÀ࣡£Äã˵ÕâÄܳԵÃˬ£¿
Óн²¾¿µÄµê£¬²ÅÊÇÕæÕýµÄÄϰ×ζµÀ
µ«ÊÇ£¬ÎÒ¸úÄ㽲Ŷ£¬Äϰ׶«´ó½ÖÒ²ÓÐЩµê£¬Ó²ÊÇÓе㶫Î÷ÔÚÀïÃæàç¡£±ÈÈçÓмÒרÃÅÂô×ñÒå¶¹»¨·¹µÄµê£¬ÃÅÃæÐ¡µÃÏñ¸ö´òÂ齫µÄÆÌ×Ó£¬µ«Äã½øÈ¥Á˾ÍÏþµÃʲô½Ð¡°ÕæÏ㡱¡£¶¹»¨»¬µÃÏñÀì½µÄË®£¬·¹ÖóµÃ¿Å¿Å·ÖÃ÷£¬¼ÓÉϵãÀ±½·½´£¬ßõßõßõ£¬ÄÜÈÃÄã³ÔµÃÂúÍ·´óº¹»¹Òªº°¡°Ë¬ËÀÁË£¡¡±
ÀÏ×Ó͵͵¸úÄã½²£¬Äϰ׶¹»¨·¹µÄ¾«ËèŶ£¬²»ÊǶ¹»¨£¬ÊÇÀ±½·½´£¡Õý×ÚµÄÀ±½·½´ÊÇÓÃ×ñÒå±¾µØµÄºìÀ±½·³´³öÀ´£¬ÔÙ¼ÓµãËâÈØ¡¢»¨½·ÓÍÒ»Æð°¾¡£ÄÇÏãζ£¬Ó²ÊÇÄܰÑÅԱ߷¹µêµÄÏã¹øÏãÆøÑ¹ÏÂÈ¥£¡ÄãÒªÊÇÈ¥Äϰ׳Է¹£¬¿´µ½ÓÐÀϰåÔÚÃſڳ´À±½·½´£¬È¥ÊÔÊÔ£¬¾ø¶Ô²»¿÷£¡
ÄãÏþµÃû£¬Ê±¼äÒ²ºÜÖØÒªà磡
»¹Óп©£¬ºÜ¶àÈ˲»ÏþµÃ£¬ÆäʵÄϰ׶«´ó½Ö³Ô¿ì²ÍÓиö½²¾¿£¬¾ÍÊÇ¡°³Ô·¹µÄµã¡±¡£ÄãÒªÊÇÔçÉÏ9µãÈ¥£¬»ù±¾ÉϳԵÄÊÇÍ·¹ø·¹£¬²Ëζ»¹¿ÉÒÔ£»µ½ÁËÖÐÎç12µã£¬ÄÇЩÈËÁ÷¶àµÃÏñÁøÖÝ»ð³µÕ¾£¬²Ë¾Í¿ªÊ¼ÂÒÁË£¬ºÜ¶àÊdz´Ê£µÄ¡£Äã½²ÂÕâÖÖ·¹£¬ÄܳԵð²ÒÝ£¿ËùÒÔ£¬Òª³ÔÄϰ׿ì²Í£¬×îºÃÔçÉÏÈ¥£¬»òÕßÏÂÎç2µãÒÔºó£¬ÈËÉÙ¡¢²ËУ¬²Å½Ðˬ£¡
ºóÊÖÎÊÌ⣺ÓÐÈËÎÊÎÒ£¬¡°Äã½²ÄÇô¶à£¬Äǵ½µ×Ñ¡Äļң¿¡±
ÕÕÎÒ¿´¿©£¬Ñ¡²Ë¶àµÄ¡¢À±½·½´ÏãµÄ¡¢ÀϰåÄï²»ÂÒ¼ÓÇ®µÄ£¡ÄãÈ¥ÊÔÊÔ½ÖβÄǼҶ¹»¨·¹µê£¬ÃÅÃæÀõÃÏñ¶«Ïï×ÓÀïµÄÀÏ¾ÆÆÌ£¬µ«Î¶µÀµõ´òÆäËûµÄ¿ì²Íµê£¬³ÔÁËÄã¾ÍÏþµÃÎÒ½²µÃ¶Ô²»¶Ô£¡
±êÇ©
- ×ñÒåÄϰ׶«´ó½Ö¿ì²Í¶àÉÙÇ®
- ¶¹»¨·¹
- ¿ì²ÍèÄå
- ×ñÒåÀ±½·½´
- ³Ô·¹Ê±¼ä½²¾¿
¡¶Í¬³ÇÃâ·ÑÔ¼ÅÜÆ½Ì¨ÍøÕ¾¡·
ÔÚ¼à¹ÜÓë¹ú¼Ê±ê×¼²ãÃæ£¬Ò«ËٿƼ¼½üÆÚÈ¡µÃÖØÒª½øÕ¹¡£¹«Ë¾Æ÷¹ÙоƬƽ̨´Ó 2023 Ä꿪ʼÓë 3Rs ×éÖ¯ºÍ FDA ¿ªÕ¹ºÏ×÷£¬²¢ÓÚ½ñÄêÒ»ÔÂÕýʽ±»ÃÀ¹úʳƷҩƷ¼à¶½¹ÜÀí¾Ö£¨FDA£©½ÓÊÕ½øÈëÆä´´Ð¿ÆÑ§Óë¼¼ÊõÍÆ½ø¼Æ»®£¨ISTAND£¬Innovative Science and Technology Approaches for New Drugs£©µÄÆÀÉóͨµÀ£¬ÓÐÍû³ÉΪȫÇòÊ×Åú»ñµÃ FDA ¿ÆÑ§ÈÏ¿ÉÓë×ʸñÈ϶¨µÄÒ©Î↑·¢¹¤¾ß£¨Drug Development Tool£¬DDT£©¡£Ôڸ÷¾¶Ï£¬Ïà¹Ø¼¼ÊõÒ»µ©Íê³É¼à¹Ü²ãÃæµÄÑéÖ¤£¬½«¿É±»Ò©ÆóÖ±½Ó×÷ΪºÏ¹æ¹¤¾ßÓÃÓÚÐÂÒ©Ñз¢£¬²¢½øÈë IND É걨¼°ºóÐø¿ª·¢Á÷³Ì£¬ÏÔÖø½µµÍÒ©ÎïÑз¢ÖеIJ»È·¶¨ÐÔÓëÖØ¸´ÊµÑé³É±¾¡£ÕâÒ»½øÕ¹±êÖ¾×ÅÒ«ËٿƼ¼µÄƽ̨ÄÜÁ¦Õý´ÓÑз¢¹¤¾ß²ãÃæ£¬Ïò¼à¹ÜÈϿɵĻù´¡ÉèÊ©¼¶ÄÜÁ¦¼ÓËÙÑݽø¡£
¡¶soul kp°µÓï¡·
×÷Ϊºì¶¹¹É·ÝµÄ±ê¸Ë²úÆ·£¬0¸ÐÊæÊʳÄÉÀ×Ô1.0ÃæÊÀÒÔÀ´Àú¾2.0¡¢3.0ËÄÄêµü´ú£¬Æ¾½è³öÖÚÆ·ÖÊÊÕ»ñÊг¡¸ß¶ÈÈϿɣ¬µ¥¿îÏúÁ¿Í»ÆÆ200Íò¼þ£¬Õ¶»ñɳÀûÎÄ¡¢Å·î£Á½´óȨÍþ»ú¹¹ÈÏÖ¤£¬×øÎÈÊæÊʳÄÉÀÁìÓòÍ·²¿Î»Öá£
¡¶»ð³µÕ¾Ò»°ã¶¼Óм¦¡·
±¾¼¤Àø¼Æ»®ÊÚÓ輤Àø¶ÔÏóÏÞÖÆÐÔ¹ÉÆ±µÄÊÚÓè¼Û¸ñΪ 25.50 Ôª/¹É¡££¨Ä¿Ç°¹É¼Û 46.42 Ôª£©
ÆÀÂÛ1:º£¿µ·þÎñÆ÷ÃÜÂë